Long Story Short Episode 62: Therapeutic Apheresis and Long COVID
25 min
This study demonstrates the reduction in autoantibodies, inflammatory biomarkers, and erythrocyte stacking when extracorporeal apheresis is performed. Possibly an important intervention for patients that are struggling with long COVID for a prolonged period of time and are refractory to other therapies.
We believe knowledge should be accessible to everyone-no paywalls, no barriers,
just open doors to honest medicine.
We can’t do this alone; it is only possible because of the generosity of supporters. We suggest a donation of $50 to $100. But please know: every dollar counts, and your support-at any level-helps us continue this vital work and keep our resources free for all.
Support our Work